Specific protein degradation is getting explored in its place approach in cancer, whereby the normal protein degradation procedure is co-opted for therapeutic purposes. Just lately made novel molecules called proteolysis-concentrating on chimeras (PROTACs) are heterobifunctional molecules with two ligands joined by a linker. A single ligand binds for the ‘protein https://www.directivepublications.org/journal-of-clinical-breast-cancer/